http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0018435-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1165713ae56405c835462e83c1d43c10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6eaaaac903c56d7b0a3de1d047337d3b
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5152
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-468
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2809
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46
filingDate 1999-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_778cb7aba9def351d93fa8a9f1487217
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61a0b046a68fbf77903c9da3b24449f9
publicationDate 2000-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0018435-A1
titleOfInvention Time-staggered utilization of tumor cells in combination with intact antibodies for immunization
abstract The invention relates to the time-staggered utilization of tumor cells in combination with intact, preferably heterologous antibodies for the immunization of humans and animals.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8277806-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012156430-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9017676-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108264561-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1025854-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2524699-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9750806-B2
priorityDate 1998-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-19710497-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0885614-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID617
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129624995
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395875
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67149
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395874
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408122
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128643945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5746
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID231224

Total number of triples: 45.